Beneficial Effect of Muscarinic‐2 Antagonist on Dilated Cardiomyopathy Induced by Autoimmune Mechanism against Muscarinic‐2 Receptor

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Cardiovascular Pharmacology

• Publication date

  2001-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00005344-200110001-00010PMID 11811358
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autoantibodies against M2 muscarinic receptors in patients with cardiomyopathy display non-desensitized agonist-like effects.

  1999cited by this paper
• Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure.

  1999cited by this paper
• Myocardial injury due to G-protein coupled receptor-autoimmunity.

  1998cited by this paper
• Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits.

  1997cited by this paper
• Functional epitope analysis of the second extracellular loop of the human heart muscarinic acetylcholine receptor.

  1995cited by this paper
• Dilated cardiomyopathy defines serum autoantibodies against G-protein-coupled cardiovascular receptors.

  1995cited by this paper
• Anti-beta 1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops.

  1995cited by this paper
• Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy. Correlation with disease severity and cardiac autoantibodies.

  1995cited by this paper
• Transfer of human myocarditis into severe combined immunodeficiency mice.

  1994cited by this paper
• Autoantibodies against cardiac G-protein-coupled receptors define different populations with cardiomyopathies but not with hypertension.

  1994cited by this paper
• Autoantibodies against human ventricular myosin in sera of patients with acute and chronic myocarditis.

  1994cited by this paper
• Defining criteria for autoimmune diseases.

  1994cited by this paper
• Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting.

  1993cited by this paper
• Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy.

  1993cited by this paper
• Defining criteria for autoimmune diseases (Witebsky's postulates revisited)

  1993cited by this paper
• Expression of intercellular adhesion molecule-1 on cardiac myocytes for myocarditis before and during immunosuppressive therapy.

  1993cited by this paper
• Cellular and molecular bases for the immunopathology of the myocardial cell damage involved in acute viral myocarditis with special reference to dilated cardiomyopathy.

  1992cited by this paper
• Increased level of HLA-DR-expressing T lymphocytes in peripheral blood from patients with idiopathic dilated cardiomyopathy.

  1991cited by this paper
• Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy.

  1990cited by this paper
• Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy.

  1990cited by this paper
• Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy.

  1990cited by this paper
• Inappropriate major histocompatibility complex expression on cardiac tissue in dilated cardiomyopathy. Relevance for autoimmunity?

  1990cited by this paper
• Laminin distribution and autoantibodies to laminin in dilated cardiomyopathy and myocarditis.

  1989cited by this paper
• Cardiac myosin induces myocarditis in genetically predisposed mice.

  1987cited by this paper
• Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy.

  1985cited by this paper
• T-lymphocyte subsets in idiopathic dilated cardiomyopathy.

  1985cited by this paper
• Demonstration of organ specific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart diseases.

  1984cited by this paper
• Reduced Suppressor Cell Activity in Congestive Cardiomyopathy and in Myocarditis

  1982cited by this paper
• Deficient natural killer cell activity in patients with idiopathic dilated cardiomyopathy.

  1982cited by this paper
• Defective In Vitro Suppressor Cell Function in Idiopathic Congestive Cardiomyopathy

  1979cited by this paper

• Autoantibodies and Cardiomyopathy: Focus on Beta-1 Adrenergic Receptor Autoantibodies

  2022cites this paper
• Autoantibodies against M5-muscarinic and beta1-adrenergic receptors in periodontitis patients

  2020cites this paper
• Autoantibodies Specifically Against β1 Adrenergic Receptors and Adverse Clinical Outcome in Patients With Chronic Systolic Heart Failure in the β-Blocker Era: The Importance of Immunoglobulin G3 Subclass.

  2016cites this paper
• Autoantibodies and Cardiovascular Dysfunction: Cause or Consequence?

  2014cites this paper
• Muscarinic acetylcholine receptor-interacting proteins (mAChRIPs): targeting the receptorsome.

  2012cites this paper
• Autoantibodies Enhance Agonist Action and Binding to Cardiac Muscarinic Receptors in Chronic Chagas' Disease

  2008cites this paper
• Effects on heart rate of an anti‐M2 acetylcholine receptor immune response in mice

  2005cites this paper
• Is cardiomyopathy an autoimmune disease?

  2002cites this paper
• Who are the enemies? Inflammation and autoimmune mechanisms

  2002cites this paper
• Prevention of Experimental Autoimmune Cardiomyopathy in Rabbits by Receptor Blockers

  2001cites this paper